SCHEMBL25752314

SCHEMBL25752314

Cc1ccc(S(=O)(=O)OCC(=O)Nc2ccc(C=O)c(O)c2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 2/20 0.71
CTDSP1 Q9GZU7 1/20 0.71
SIRT5 Q9NXA8 1/20 0.71
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
ALDH1A1 P00352 1/20 0.43
NCOA1 Q15788 1/20 0.43
NCOA3 Q9Y6Q9 1/20 0.43
P2RY14 Q15391 1/20 0.43
POLB P06746 3/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAPK1 P28482 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4456216 0.83 STAT3 (1.00) STAT3CTDSP1SIRT5KDM4EMEN1
SCHEMBL31249645 0.83 STAT3 (1.00) STAT3CTDSP1SIRT5KDM4EMEN1
SCHEMBL2000416 0.80 STAT3 (0.74) STAT3CTDSP1SIRT5KDM4EMEN1
SCHEMBL12359433 0.80 STAT3 (0.94) STAT3CTDSP1SIRT5KDM4EMEN1
SCHEMBL1998361 0.78 STAT3 (0.78) STAT3CTDSP1SIRT5KDM4EMEN1
SCHEMBL1999371 0.77 STAT3 (1.00) STAT3CTDSP1SIRT5MEN1KMT2A
SCHEMBL12359466 0.77 STAT3 (0.81) STAT3CTDSP1SIRT5KDM4EMEN1
SCHEMBL25752409 0.76 STAT3 (0.79) STAT3CTDSP1SIRT5MEN1KMT2A
SCHEMBL2002782 0.75 STAT3 (0.69) STAT3CTDSP1SIRT5MEN1KMT2A
SCHEMBL11658456 0.74 RAD51 (0.58) MEN1KMT2ACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212568-A1 MICRORNA-MEDIATED METHODS FOR REJUVENATING CNS GLIAL POPULATIONS UNIVERSITY OF ROCHESTER 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212568-A1 MICRORNA-MEDIATED METHODS FOR REJUVENATING CNS GLIAL POPULATIONS MYT1, STAT3, MYC STAT3 2/4885CTDSP1 3329/4885SIRT5 295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.